The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris
Abstract
Summary Candida auris has caused nosocomial infections and transmissions within hospital settings. As little is known about the efficacy of skin and environmental decontamination products to kill C. auris, this study investigated the in vitro activity of chlorine, chlorhexidine, iodine povidone and vaporised hydrogen peroxide products against C. auris. H2O2 vapour showed 96.6%‐100% effective killing of C. auris. All isolates were inhibited by chlorhexidine gluconate concentrations at 0.125%‐1.5% and for iodinated povidone at 0.07%‐1.25%. Other species of Candida were also killed at 1000 ppm chlorine except C. parapsilosis which failed to be killed at 3 minutes contact time. We conclude that chlorhexidine gluconate, iodinated povidone, chlorine and H2O2 vapour demonstrate effective killing activity against C. auris at concentrations used in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The age of the individual has been reported as a predisposing factor for C. auris skin colonization in some studies, with C. auris-colonized patients aged 65–80 years at greater risk [62–64].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [64]
In the citing paper
“C. auris demonstrates a remarkable ability to persist on both host skin and inanimate objects for extended periods of time, posing great challenges to eradicate from hospital settings.”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [64]
In the citing paper
“Notably, many hospital-grade disinfectants have limited efficacy against C. auris [12,64,65].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [64]
Citations
Cites
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768
Self-citationChowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750
Welsh, R. M., Bentz, M. L., Shams, A., Houston, H., Lyons, A., Rose, L. J., & Litvintseva, A. P. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-17 · Cited by 499
Calvo, B., Melo, A. S. D. A., Mena, A. J. P., Hernandez, M., Francisco, E. C., Hagen, F., Meis, J. F. G. M., & Colombo, A. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.008 · Cited by 448
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
Sherry, L., Ramage, G., Kean, R., Borman, A., Johnson, E. M., Richardson, M. D., & Rautemaa-Richardson, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.161320 · Cited by 420
Candida auris candidaemia in Indian ICUs: analysis of risk factors
Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357
Vallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., Kemble, S. K., Pacilli, M., Black, S. R., Landon, E., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6544e1 · Cited by 302
Invasive Infections with Multidrug-Resistant Yeast Candida auris , Colombia
Morales-López, S. E., Parra‐Giraldo, C. M., Ceballos-Garzón, A., Martínez, H. P., Rodríguez, G. J., Álvarez, C., & Rodríguez, J. Y. (2016) · Emerging infectious diseases · doi:10.3201/eid2301.161497 · Cited by 244
Multidrug-resistant Candida auris: ‘New kid on the block’ in hospital-associated infections?
Chowdhary, A., Voss, A., & Meis, J. F. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.004 · Cited by 214
Flagged first, then by citations
Research works printed but not linked: 1
- Bioquell Hydrogen Peroxide Vapour (HPV) biological efficacy.https://doi.org/http://healthcare.bioquell.com/en-uk/resources-and-support/efficacy/. Accessed 23 May 2017.
Cited by
Sorted by citations
Items 101–150 of 150
Ogundeji, A. O., Bello‐Akinosho, M., Swart, V. R., Featherston, J., Cason, E. D., Bolsenbroek, A., Beneke, C., Musoke, J., Baker, T., Ismail, A., et al. (2025) · Medical Mycology · doi:10.1093/mmy/myaf069 · Cited by 8
The Importance of Candida auris in Skin
Montoya, A. M. (2024) · Current Fungal Infection Reports · doi:10.1007/s12281-024-00487-3 · Cited by 6
Candida auris in intensive care unit: A growing clinical concern
Bassetti, M., Magnasco, L., Lamarina, A., Paola, L. D., Vena, A., Giacobbe, D. R., & Bartalucci, C. (2025) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-25-00003 · Cited by 7
Hassan, Y., & Sule, H. (2023) · Academia Biology · doi:10.20935/acadbiol6074 · Cited by 7
Candida auris: Problems in Diagnostics and Management
Ivanov, A. A., & Kulichenko, T. V. (2020) · Вопросы современной педиатрии · doi:10.15690/vsp.v19i1.2081 · Cited by 6
Future Directions for Clinical Respiratory Fungal Research
Armstrong-James, D. P. H. (2021) · Mycopathologia · doi:10.1007/s11046-021-00579-5 · Cited by 6
Self-citationCan chlorhexidine gluconate baths reduce fungal colonisation in intensive care unit patients?
Nascimento, T., Inácio, J., Guerreiro, D., Patrício, P., Proença, L., Toscano, C., Diaz, P., & Barroso, H. (2025) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-025-01606-6 · Cited by 5
Anirima, K., Kokkayil, P., Sarfraz, A., Chowdhry, B. K., Thakuria, B., & Pati, B. K. (2024) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2024.101671 · Cited by 5
Micelly-Moreno, J., Barreto-Santamaría, A., Arévalo‐Pinzón, G., Firacative, C., Gómez, B. L., Escandón, P., Patarroyo, M. A., & Muñoz, J. E. (2023) · Journal of Fungi · doi:10.3390/jof9121149 · Cited by 4
Host–Candida auris interactions in the skin
Thangamani, S., Balakumar, A., Datta, A., Bryak, G., & Lionakis, M. S. (2026) · PLOS Pathogens · doi:10.1371/journal.ppat.1014075 · Cited by 3
Detection and Control of Candida auris in Healthcare Settings
Kwon, Y. J., & Shin, J. H. (2022) · Korean Journal of Healthcare-Associated Infection Control and Prevention · doi:10.14192/kjicp.2022.27.1.4 · Cited by 3
Andreu‐Vilarroig, C., Cortés, J. ‐., Pérez, C.-L., & Villanueva, R. J. (2023) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2023.129254 · Cited by 3
Contamination of tissue allografts from a multiorgan‐multitissue donor colonized by Candida auris
Mirabet, V., Artigues, E., Galán, J., Escobedo‐Lucea, C., Larrea, L., Arbona, C., Gimeno, C., & Pemán, J. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13535 · Cited by 3
The Potential of Dutasteride for Treating Multidrug-Resistant Candida auris Infection
Borgio, J. F., Almandil, N. B., Selvaraj, P., Sherlin John, J., Alquwaie, R., Alhasani, E. S., Alhur, N. F., Aldahhan, R., AlJindan, R. Y., Almohazey, D., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060810 · Cited by 3
Pritulo, O. A., Borodavkin, D. V., Kasaeva, G. R., & Равлюк, Д. А. (2023) · Russian Journal of Skin and Venereal Diseases · doi:10.17816/dv567955 · Cited by 2
Papadimitriou, A., Drosopoulou, L.-P., Tseroni, M., Kontopidou, F. V., Tsakris, A., & Vrioni, G. (2026) · Journal of Fungi · doi:10.3390/jof12020131 · Cited by 2
Biocide Response of Candida auris
Erganiş, S., Öztürk, A., Şahin, E. A., & KALKANCI, A. (2026) · Mycoses · doi:10.1111/myc.70169 · Cited by 2
Kampf, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-66074-0_18 · Cited by 2
Review on some current skin antiseptics.
Dopcea, G. N., & Matei, F. (2018) · Scientific Bulletin. Series F. Biotechnologies · Cited by 2
Guo, X.-J., Zhang, Y., Li, P., & Guo, J. (2020) · European Journal of Inflammation · doi:10.1177/2058739220942647 · Cited by 2
Kumar, A., Singh, N., Das, A., & Agarwal, J. (2025) · Cureus · doi:10.7759/cureus.90131 · Cited by 1
Increasing threat to the healthcare setting: Candida auris
McDougal, A. N., & Ostrosky-Zeichner, L. L. (2026) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001210 · Cited by 1
Ramage, G., Kean, R., Mackay, W. G., Vaccaro, A., Lopez-Ribot, J. L., & Howe, M. H. (2025) · Springer series on biofilms · doi:10.1007/978-3-031-93315-8_7 · Cited by 1
Santos, S. R. D., Stempinski, P. R., Wieren, A. V., Gerbig, G. R., Smith, D. F. Q., Zamith‐Miranda, D., Nosanchuk, J. D., & Casadevall, A. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02897-25 · Cited by 1
Candida auris: What We Need to Know in Healthcare Settings
Nowbakht, C., & Ostrosky-Zeichner, L. L. (2018) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-018-0168-6 · Cited by 1
Candida auris: Steckbrief eines neuen Pilzes
Wagener, J., & Kurzai, O. (2019) · Deutsches Ärzteblatt · doi:10.3238/persinfek.2019.07.22.01 · Cited by 2
Cutaneous Fungal Infections in Left Ventricular Assist Device Recipients
Peraza, J., & Puius, Y. A. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00396-1 · Cited by 1
Kampf, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-66074-0_15 · Cited by 1
Kampf, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-98785-9_16 · Cited by 1
Schwartz, I. S., Smith, S., & Dingle, T. (2018) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v44i11a01f
Candida auris: A New, Threatening Yeast
Pemán, J., & Gaitán, A. C. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21000-5
Future Tuning Optoelectronic Oxides from the Inside: Sol‐Gel ( TiO2 )x‐( SiO2 )100‐x
Worsley, M., Leadley, J. G., MacGibbon, R. M. A., Salvesen, T., Sermon, P. A., & Charnock, J. (2021) · Wiley eBooks · doi:10.1002/9781119529538.ch14
Mechanisms of pathogenesis and drug resistance in Candida auris
WeiNa, Z. H. A. O., Zhang, B., & QiMing, W. A. N. G. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0230
Warghade, A. P., Mudey, G., Meshram, S., Kombe, S., & Shaw, D. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.3.53
The C. auris Epidemic: Understanding its Impact on ICU Patients
Ugemuge, P., Ugemuge, S., Mishra, V. H., & Tidake, A. A. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.4.57
Erganiş, S., Şahin, E. A., Öztürk, A., Yıldız, P. A., Şahin, C., Top, Ö. Ö., & Tunçcan, Ö. G. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3202
Multidrug resistance mechanisms and therapeutic strategies in Candida auris
Alkaabi, S. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20252187
Bacillus velezensis NC-B4 as a promising antifungal agent for biocontrol of Candida auris
Yang, C., Cui, C., Chen, Y., & Peng, Z. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1515537
The Rise of Candida auris: A Global Health Threat
Warrier, A. R., & Moses, S. S. (2025) · Infectious diseases · doi:10.5772/intechopen.1012838 · Cited by 1
Jordan, V. S., Perera, M., Unsworth, A., Basile, K., Halliday, C., & Chen, S. C.-A. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2634539
Methods for skin load reduction of Candida auris: a systematic review
Du, Y., Lu, Y., Qiao, F., Jin, H., Lin, S., Wang, Z., Mandizadza, O. O., Ji, C., & Gan, T. (2026) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-026-01719-6
Kemmerich, K. K., Alves, L. R., de Almeida, J. N., Colombo, A. L., & Alves, L. R. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002135
Xie, Z., Li, Y., Yang, F., Liu, W., Cai, R., & Lu, Y. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05088-3
Bode, M., Lydecker, A. D., Robinson, G. L., Roghmann, M., & Kalan, L. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag697
Clinical implications in patients with isolation of Candidozyma auris in a single tertiary hospital
Kim, T., Kim, Y. J., & Lee, Y. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13963-7
Osama, D., Alsedawy, M., Hussein, M. S., Hassan, M. A., Elrefaey, S. M., & Tawfick, M. M. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02393-9
A systematic review on an alarming global public health threat: Candida auris
Ghedia, B. J. (2026) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.16045.1784703339
de Sousa, D. S. M., Cabral, A. K. L. F., Arantes, B. B. A., Sato, J. H. A., Monari, G. P. D. M., Ruiz, L. D. S., Elgammal, Y., Martinez, L. R., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2026) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2026.2727050
Caggiano, G., Triggiano, F., Fioriti, S., D’Achille, G., Rochira, N., Diella, G., Spagnuolo, V., Lopuzzo, M., Dalfino, L., Stufano, M., et al. (2026) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2026.103404
Purine metabolism dysregulation as a multi-omics signature of fatal Candida auris infection
Bataineh, M. T. A., Barreiros, A. S., Sreedharan, S. P., Dash, N. R., Mudalagiriyappa, S., Alkhayyal, N., Al‐Omari, B., & Alnaqbi, H. (2026) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2026.2735107
Metadata
- Authors
- Abdolrasouli, A., Armstrong‐James, D., Ryan, L., & Schelenz, S.
- Affiliations
- Imperial College London (GB)
- Fungal Pathogens Laboratory National Heart and Lung Institute Imperial College London London UK
- Royal Brompton Hospital (GB)
- Corresponding author
- Schelenz, Silke
- Venue
- Mycoses
- Publisher
- Wiley
- Published
- 2017-09-15
- Volume
- 60
- Issue
- 11
- Pages
- 758-763
- ISSN
- 0027-5557 (ISSN-L)
- 0933-7407
- 1439-0507
- OpenAlex
- W2753228732
- Cited by
- 150
- References
- 15
- Citations by year
- 2026: 15 · 2025: 12 · 2024: 15 · 2023: 21 · 2022: 9 · 2021: 13 · 2020: 17 · 2019: 22 · 2018: 21 · 2017: 5
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Mycoses (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Keywords
- Candida auris, environmental decontamination, hospital outbreak, chlorhexidine gluconate, povidone-iodine, chlorine, hydrogen peroxide vapor, Candida parapsilosis, nosocomial fungal infections
- MeSH terms
- Candida, Candidiasis, Chlorhexidine, Chlorine, Cross Infection, Decontamination, Disease Outbreaks, Disinfectants, Hospitals, Humans, Hydrogen Peroxide, Povidone-Iodine, Volatilization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
